DUN & BRADSTREET NETPROSPEX, INC. – Trademark Portfolio
Entity Type: 03
DUN & BRADSTREET NETPROSPEX, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CLENESTEP and DATA HEALTHSCAN. The owner is based in Jacksonville, FL.
5335 Gate Parkway
Jacksonville, FL 32256
Showing of trademarks Trademarks
Trademark Classifications
DUN & BRADSTREET NETPROSPEX, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does DUN & BRADSTREET NETPROSPEX, INC. have?
DUN & BRADSTREET NETPROSPEX, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 cancelled.
What trademark classes does DUN & BRADSTREET NETPROSPEX, INC. file in?
DUN & BRADSTREET NETPROSPEX, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are DUN & BRADSTREET NETPROSPEX, INC.'s most well-known trademarks?
DUN & BRADSTREET NETPROSPEX, INC.'s registered trademark portfolio includes well-known marks such as CLENESTEP and DATA HEALTHSCAN. These are among 2 currently registered trademarks in the portfolio.
What is DUN & BRADSTREET NETPROSPEX, INC.'s trademark registration success rate?
DUN & BRADSTREET NETPROSPEX, INC. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.